Global Blood Therapeutics Inc (NASDAQ:GBT): Steve Cohen’s Point72 Asset Management filed an amended 13D.
You can check out Point72 Asset Management’s latest holdings and filings here.
Please follow Point72 Asset Management (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Point72 Asset Management or update its stock holdings.

You can access the original SEC filing by clicking here.
Ownership Summary Table
Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
---|---|---|---|---|---|---|
Point7 | 0 | 2,268,800 | 0 | 2,268,800 | 2,268,800 | 5.2% |
Point7 | 0 | 2,268,800 | 0 | 2,268,800 | 2,268,800 | 5.2% |
Cubist Systematic Strategies | 0 | 6,699 | 0 | 6,699 | 6,699 | Less than 0.1% |
Point7 | 0 | 828 | 0 | 828 | 828 | Less than 0.1% |
Steven A. Cohen | 0 | 2,276,327 | 0 | 2,276,327 | 2,276,327 | 5.2% |

Page 1 of 11 – SEC Filing
(Amendment No. )*
GLOBAL BLOOD THERAPEUTICS, INC.
Common Stock, Par Value $0.001 Per Share
☐ | Rule 13d-1(b) | |
☒ | Rule 13d-1(c) | |
☐ | Rule 13d-1(d) |